Differentiating Flail Limb Syndrome From Amyotrophic Lateral Sclerosis

Area of Science:

• Neurology
• Neuronopathy

Background:

• Flail limb syndrome (FLS) and amyotrophic lateral sclerosis (ALS) are progressive neurodegenerative disorders.
• Distinguishing between FLS and ALS is crucial for prognosis and management.

Purpose of the Study:

• To investigate and compare key clinical and electrophysiological parameters between FLS and ALS.
• To identify potential indicators for FLS progression to ALS.

Main Methods:

• Retrospective chart review of 16 FLS and 16 ALS patients.
• Comparison of Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) decline, compound muscle action potential (CMAP) amplitudes, and vital capacity (VC) loss rate.

Main Results:

• Patients with ALS showed a significantly higher rate of vital capacity loss (5.26% ± 0.33% per month) compared to FLS patients (0.54% ± 0.06% per month).
• FLS patients had significantly lower average ulnar nerve CMAP amplitudes.
• No significant differences were found in ALSFRS-R decline or other tested nerve CMAP amplitudes.

Conclusions:

• A monthly vital capacity decrease exceeding 0.65% in FLS may suggest progression towards ALS.
• Further prospective studies are needed to validate these findings and establish predictive markers for FLS progression.